Credit: Adobe Stock/eddows Clinical, endoscopic, and laboratory assessments revealed the infliximab biosimilar CT-P13 was comparable to the reference drug in terms of safety and efficacy among...
During National Cystic Fibrosis Awareness Month, UB highlights its commitment to studying and keeping up with the dramatic advances in treating CF BUFFALO, N.Y. – During...
Yanjie Hao, PhD Credit: Asia Pacific Lupus Collaboration A treat-to-target (T2T) strategy was shown to significantly improve both clinical outcomes and health-related quality of life (HRQoL)...
A matching-adjusted indirect comparison of eGFR slopes from the PROTECT trial, the NefIgArd trial, and the RaDaR registry is offering new insight into the effects of...